Department of Pharmacy and Pharmacology


Professor of Medicinal and Biological Chemistry

5 West - 3.3


Tel: +44 (0) 1225 386639


Professor Potter's research homepage


Prof Barry Potter FMedSci



Professor Potter studied chemistry at Oxford, completing his D.Phil on the stereochemistry of enzyme-catalysed phosphoryl transfer, developing the [16O,17O,18O] chiral phosphate approach. After postdocs at Oxford and the Max-Planck-Institute for Experimentelle Medizin in Germany he became Lecturer in Biological Chemistry at Leicester, winning a Lister Institute Fellowship, moving to the Established Chair of Medicinal Chemistry at Bath as Head of Section. He is Visiting Professor at Oxford University and, from 2013, a Wellcome Trust Senior Investigator.

Research (see my research homepage) is at Chemistry-Biology and Chemistry-Medicine interfaces, in Signal Transduction, Anticancer Drug Discovery and Translational & Molecular Medicine. Particular interests are synthetic chemical biology tools in cell-signalling by calcium-mobilising second messengers. In Medicinal Chemistry, he has pioneered a new pharmacophore, bringing compounds from novel therapeutic concept to 18 Phase I and II clinical trials in oncology and women’s health. Bath drugs are in human trials in metastatic breast cancer, endometrial cancer, prostate cancer and endometriosis. He co-founded Sterix, a spin-out company acquired by major pharma.

He was a member of the RAE2001 and RAE2008 Panels, 2009 REF Expert Group Panel, Wellcome Trust Molecules, Genes & Cells Funding Panel (2006-2011), BBSRC Intracellular Signalling Programme Committee and the EPSRC Synthetic and Biological Chemistry College and is currently a member of the Wellcome Trust Peer Review College. He is on editorial boards including the Journal of Medicinal Chemistry, Molecular Cancer Therapeutics, ChemMedChem and is Associate Editor of the Journal of Steroid Biochemistry & Molecular Biology and an Editor of the Biochemical Journal's BJChemBio.

Professor Potter is a Fellow of the Royal Society of Chemistry (RSC) and the Society of Biology and Fellow of the Academy of Medical Sciences (2008) and Member of Academia Europaea (2009). He has won major prizes:

  • 2007 RSC Medal for Chemical Biology
  • 2007/8 RSC George and Christine Sosnovsky Medal
  • 2009 RSC Malcolm Campbell Medal
  • 2009 GlaxoSmithKline International Achievement Award
  • 2010 RSC Interdisciplinary Medal 
  • 2012 European Life Sciences Awards "Investigator of the Year"
  • 2015/16 RSC-BMCS Medicinal Chemistry Lectureship


Read publications by Barry Potter

View more publications »